Glycinebetaine

Glycinebetaine

SCHEMBL4255367

C[N+](C)(C)CC(=O)[O-].P

nearest known ligand 0.00

Full drug profile on Sugi Atlas →

Known targets — ChEMBL curated mechanism

BHMTBHMT2

The experimentally established mechanism targets of Glycinebetaine. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Glycinebetaine SCHEMBL8678519 0.97 TSHR (0.53)
Glycinebetaine SCHEMBL2803780 0.97 TSHR (0.53)
Betaine SCHEMBL31467313 0.97
Glycinebetaine SCHEMBL7739 0.97
Glycinebetaine SCHEMBL4900209 0.97
Glycinebetaine SCHEMBL11109389 0.94
Glycinebetaine SCHEMBL4457941 0.94 TSHR (0.50)
Glycinebetaine SCHEMBL8388807 0.94
Glycinebetaine SCHEMBL8725957 0.94
Glycinebetaine SCHEMBL20703289 0.94

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 18 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20150346188-A1 STABILIZED NANOPORE AND MICROPORE STRUCTURES AND METHODS FOR MAKING AND USING THE SAME IBIS BIOSCIENCES, INC. 2015-12-03 US claimed
EP-2935664-A1 STABILIZED NANOPORE AND MICROPORE STRUCTURES AND METHODS FOR MAKING AND USING THE SAME Ibis Biosciences, Inc. (US) 2015-10-28 EP claimed
WO-2014100693-A1 STABILIZED NANOPORE AND MICROPORE STRUCTURES AND METHODS FOR MAKING AND USING THE SAME IBIS BIOSCIENCES, INC. (US) 2014-06-26 WO claimed
EP-4234718-A2 METHODS AND COMPOSITIONS FOR STABILIZING NUCLEIC ACID-NUCLEOTIDE-POLYMERASE COMPLEXES Pacific Biosciences Of California, Inc. (US) 2023-08-30 EP disclosed
EP-3784800-B1 METHODS AND COMPOSITIONS FOR STABILIZING NUCLEIC ACID-NUCLEOTIDE-POLYMERASE COMPLEXES PACIFIC BIOSCIENCES CALIFORNIA INC (US) 2023-05-03 EP disclosed
WO-2023023116-A1 BROAD SPECTRUM ANTI-MICROBIAL POLYMERIC COMPOSITION CORNELL UNIVERSITY (US) 2023-02-23 WO disclosed
US-20220290216-A1 METHODS AND COMPOSITIONS FOR STABILIZING NUCLEIC ACID-NUCLEOTIDE-POLYMERASE COMPLEXES Omniome, Inc. (US) 2022-09-15 US disclosed
CN-109824543-B Compound, liquid crystal composition and application thereof 江苏和成显示科技有限公司 2022-02-22 CN disclosed
US-11242557-B2 Methods and compositions for stabilizing nucleic acid-nucleotide-polymerase complexes Omniome, Inc. (US) 2022-02-08 US disclosed
EP-3784800-A1 METHODS AND COMPOSITIONS FOR STABILIZING NUCLEIC ACID-NUCLEOTIDE-POLYMERASE COMPLEXES Omniome, Inc. (US) 2021-03-03 EP disclosed
CN-109134423-B Compound, liquid crystal composition thereof and photoelectric display device 江苏和成显示科技有限公司 2020-03-17 CN disclosed
US-20190345544-A1 METHODS AND COMPOSITIONS FOR STABILIZING NUCLEIC ACID-NUCLEOTIDE-POLYMERASE COMPLEXES Omniome, Inc. (US) 2019-11-14 US disclosed
US-10400272-B1 Methods and compositions for stabilizing nucleic acid-nucleotide-polymerase complexes Omniome, Inc. (US) 2019-09-03 US disclosed
US-20150346188-A1 STABILIZED NANOPORE AND MICROPORE STRUCTURES AND METHODS FOR MAKING AND USING THE SAME IBIS BIOSCIENCES, INC. 2015-12-03 US disclosed
EP-2935664-A1 STABILIZED NANOPORE AND MICROPORE STRUCTURES AND METHODS FOR MAKING AND USING THE SAME Ibis Biosciences, Inc. (US) 2015-10-28 EP disclosed
WO-2014100693-A1 STABILIZED NANOPORE AND MICROPORE STRUCTURES AND METHODS FOR MAKING AND USING THE SAME IBIS BIOSCIENCES, INC. (US) 2014-06-26 WO disclosed
US-20090215933-A1 Alicyclic Polyester and Process for Producing the Same, and Resin Composition Using the Same MITSUBISHI CHEMICAL CORPORATION (JP) 2009-08-27 US disclosed
EP-1903067-A1 ALICYCLIC POLYESTER, PROCESS FOR PRODUCING THE SAME, AND RESIN COMPOSITION Mitsubishi Chemical Corporation (JP) 2008-03-26 EP disclosed